(2015). Toll-like receptor 4 antagonist and obesity associated kidney disease: Where should we go from here? The Korean Society of Nephrology.
Chicago Style (17th ed.) CitationToll-like Receptor 4 Antagonist and Obesity Associated Kidney Disease: Where Should We Go from Here? The Korean Society of Nephrology, 2015.
MLA (9th ed.) CitationToll-like Receptor 4 Antagonist and Obesity Associated Kidney Disease: Where Should We Go from Here? The Korean Society of Nephrology, 2015.
Warning: These citations may not always be 100% accurate.